3 November 2021

Last Thursday and Friday, 21 and 22 October 2021, our RIMLS PhD candidates attended this course at the beautiful location Soeterbeeck, an ancient convent. Under supervision of Wim Bierman, 19 PhD candidates participated in the plenary and group meetings. 

Thanks to the enthusiastic support of the supervisors Rene Bindels, Clasien Oomen, Bert van der Reijden, Sander Leeuwenburgh, Nicole van der Kar, Judith Schaart, Lotte Tholen and Wim Bierman, this meeting was very well evaluated by the participants.
The aims of this course are:

  • To make PhD candidates aware that they are responsible for their PhD track. Therefore, the focus of this program is how PhD candidates can be in the lead of their PhD. They explore what drives their work as a researcher. Moreover, with supervisors, PhD candidates discuss each other's expectations. 
  • As PhD projects have challenges, PhD candidates are asked to reflect upon how they apply to each individual PhD track. Using ‘Strengthsfinder’ the attendees discover their own talents and how to use them to their advantage.
  • Finally, PhD candidates interact and network with peers.

For questions about this course, you can email  rimls.graduateschool@radboudumc.nl

    more photos


  • Want to know more about these subjects? Click on the buttons below for more news.


Related news items

Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling

11 May 2022

Bart Smeets, Jitske Jansen and collegues, theme Renal disorders published this article in the Human Development.

read more

Mani Diba joins the Department of Dentistry as Hypatia Tenure Track Fellow

10 May 2022

Mani Diba recently re-joined Radboudumc as an Hypatia Tenure Track Fellow at the research group Regenerative Biomaterials of the Department of Dentistry.

read more

Combining targeted radionuclide therapy and immune checkpoint inhibition for cancer treatment

4 May 2022

Simone Kleinendorst, Sandra Heskamp and colleagues, theme Rare cancers, published in Clinical Cancer Research about their research on combined radionuclide therapy and immunotherapy for cancer treatment.

read more